Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients : single-center UK experience
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
|---|---|
| Enthalten in: |
Leukemia & lymphoma - 62(2021), 14 vom: 19. Dez., Seite 3544-3547 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Richards, Huw [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 14.04.2022 Date Revised 14.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/10428194.2021.1961240 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328924571 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328924571 | ||
| 003 | DE-627 | ||
| 005 | 20231225204005.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10428194.2021.1961240 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1096.xml |
| 035 | |a (DE-627)NLM328924571 | ||
| 035 | |a (NLM)34348069 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Richards, Huw |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients |b single-center UK experience |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.04.2022 | ||
| 500 | |a Date Revised 14.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 700 | 1 | |a Chavda, Selina J |e verfasserin |4 aut | |
| 700 | 1 | |a Wilson, William |e verfasserin |4 aut | |
| 700 | 1 | |a Camilleri, Marquita |e verfasserin |4 aut | |
| 700 | 1 | |a Cohen, Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Horder, Jackie |e verfasserin |4 aut | |
| 700 | 1 | |a Newrick, Fiona |e verfasserin |4 aut | |
| 700 | 1 | |a Papanikolaou, Xenofon |e verfasserin |4 aut | |
| 700 | 1 | |a Sive, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Lydia |e verfasserin |4 aut | |
| 700 | 1 | |a Popat, Rakesh |e verfasserin |4 aut | |
| 700 | 1 | |a Wechalekar, Ashutosh |e verfasserin |4 aut | |
| 700 | 1 | |a Kyriakou, Charalampia |e verfasserin |4 aut | |
| 700 | 1 | |a Yong, Kwee |e verfasserin |4 aut | |
| 700 | 1 | |a Rabin, Neil |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia & lymphoma |d 1989 |g 62(2021), 14 vom: 19. Dez., Seite 3544-3547 |w (DE-627)NLM012624047 |x 1029-2403 |7 nnns |
| 773 | 1 | 8 | |g volume:62 |g year:2021 |g number:14 |g day:19 |g month:12 |g pages:3544-3547 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/10428194.2021.1961240 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 62 |j 2021 |e 14 |b 19 |c 12 |h 3544-3547 | ||